Clinical trial
"The Effect of The Combination Therapy of Statin and SGLT2i in The Treatment of Ischemic Heart Disease"
NCT06520891 is registered in ClinicalTrials.gov with Fayoum University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- "The Effect of The Combination Therapy of Statin and SGLT2i in The Treatment of Ischemic Heart Disease"
- Lead sponsor
- Fayoum University
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- June 1, 2024
- Completion date
- December 30, 2025
- Enrollment
- 90 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
2 drugs are statin and sglt2i